Reading the tape
NASDAQ: INNV
InnovAge Holding Corp.
Healthcare · Medical - Care Facilities
Market Cap
$1.11B
52w High
$10.69
52w Low
$2.84
P/E
-269.13
Volume
144.87K
Outstanding Shares
135.70M
Price vs Fundamentals
Why The Stock Is Moving
Optimism is getting priced inModerate confidence
Note: The most recent financial data is over 3 months old. Metrics shown may not reflect the latest reporting period.
1Y Price: 182.7%Revenue (TTM): 13.08%P/S: 65th pct
What changed
The stock rose 182.7% over the last year. Revenue grew 13.08% over the trailing twelve months. Operating margin moved from -3.49% to 0.45%.
What the market seems to be pricing
The stock is trading toward the richer end of its historical P/S range (65th percentile) while business metrics are improving. More of the upside is already embedded in the multiple now.
What would invalidate this read
Operating margin is at 0.45% — continued expansion would be needed to justify the premium. Revenue growth of 13.08% is encouraging, but any deceleration puts the stretched multiple at risk. This read changes if revenue, margins, and cash flow continue to improve faster than expected — in that case the richer multiple could still prove conservative.
Company profile
InnovAge Holding Corp. manages and provides a range of medical and ancillary services for seniors in need of care and support to live independently in their homes and communities.
CEOPatrick Blair
SectorHealthcare
IndustryMedical - Care Facilities
Employees2,350
IPO dateMar 4, 2021
Valuation
Forward P/E—
EV/EBITDA159.49
Enterprise value$536.52M
Stock splits
No stock splits recorded for this ticker.
Profitability & growth
Revenue growth14.69%
Gross margin19.82%▲296.21%vs FY2024
Operating margin0.45%▼14.88%vs FY2024
ROE-12.9%▼62.79%vs FY2024
Analyst consensus
RatingHold
Target price$6.80▼16.77%
0
Buy
6
Hold
2
Sell
Analyst ratings tend to be lagging indicators. Use as one signal among many.
Earnings
Full quarter-by-quarter history of actuals vs estimates. Switch into compare mode to inspect one metric year-over-year.
Next report
May 5, 2026
Q2 FY26 · EPS est $0.06 · Revenue est $234.34M
View